TY - JOUR
T1 - Long-Term Trajectories of Left Ventricular Ejection Fraction in Patients with Chronic Inflammatory Diseases and Heart Failure
T2 - An Analysis of Electronic Health Records
AU - Rivera, Adovich S.
AU - Sinha, Arjun
AU - Ahmad, Faraz S.
AU - Thorp, Edward
AU - Wilcox, Jane E.
AU - Lloyd-Jones, Donald M.
AU - Feinstein, Matthew J.
N1 - Funding Information:
We thank the American Heart Association Fellow-to-Faculty Award (16FTF31200010; Principal Investigator: Dr Feinstein) and Predoctoral Fellowship Award (825793; Principal Investigator: Dr Rivera, 2021-2023), as well as the National Institutes of Health (P30AI117943 and UL1TR001422) for funding support.
Publisher Copyright:
© 2021 American Heart Association, Inc.
PY - 2021
Y1 - 2021
N2 - BACKGROUND: Immune regulation and inflammation play a role in the pathogenesis and progression of acute and chronic heart failure (HF). Although the clinical course of acute, severe inflammatory cardiomyopathy is well described, the effects of chronic systemic inflammation on cardiovascular function over time are less clear. To investigate this question, we compared trajectories over time in left ventricular ejection fraction for patients with HF with different chronic inflammatory diseases (CIDs): HIV, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, inflammatory bowel disease, and/or psoriasis. METHODS: Using a database of patients receiving care in a large metropolitan health care system since January 1, 2000, we analyzed serial, clinically indicated echocardiograms from patients with HF with CIDs and frequency-matched patients with HF without CIDs. We included patients with ≥3 serial echocardiograms (N=974; median 6.1 years between first and most recent echo). We assessed left ventricular ejection fraction trajectories over time using latent trajectory models, then investigated differences in left ventricular ejection fraction trajectories for specific CID subtypes compared with controls. RESULTS: Overall, the majority of patients studied (N=687; 70.5%) had left ventricular ejection fraction trajectories consistent with HF with preserved or midrange EF, whereas 255 (26.2%) had HF with reduced EF and 32 (3.3%) had HF with recovered EF. Compared with non-CID controls with HF, patients with rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus were significantly more likely than controls to have HF with preserved or midrange EF whereas patients with HIV were significantly more likely to have HF with reduced EF. CONCLUSIONS: Among patients with HF with CIDs, distinct left ventricular ejection fraction trajectory patterns associate with different specific individual CIDs. This highlights the heterogeneity of HF subtypes and changes over time across different CIDs.
AB - BACKGROUND: Immune regulation and inflammation play a role in the pathogenesis and progression of acute and chronic heart failure (HF). Although the clinical course of acute, severe inflammatory cardiomyopathy is well described, the effects of chronic systemic inflammation on cardiovascular function over time are less clear. To investigate this question, we compared trajectories over time in left ventricular ejection fraction for patients with HF with different chronic inflammatory diseases (CIDs): HIV, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, inflammatory bowel disease, and/or psoriasis. METHODS: Using a database of patients receiving care in a large metropolitan health care system since January 1, 2000, we analyzed serial, clinically indicated echocardiograms from patients with HF with CIDs and frequency-matched patients with HF without CIDs. We included patients with ≥3 serial echocardiograms (N=974; median 6.1 years between first and most recent echo). We assessed left ventricular ejection fraction trajectories over time using latent trajectory models, then investigated differences in left ventricular ejection fraction trajectories for specific CID subtypes compared with controls. RESULTS: Overall, the majority of patients studied (N=687; 70.5%) had left ventricular ejection fraction trajectories consistent with HF with preserved or midrange EF, whereas 255 (26.2%) had HF with reduced EF and 32 (3.3%) had HF with recovered EF. Compared with non-CID controls with HF, patients with rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus were significantly more likely than controls to have HF with preserved or midrange EF whereas patients with HIV were significantly more likely to have HF with reduced EF. CONCLUSIONS: Among patients with HF with CIDs, distinct left ventricular ejection fraction trajectory patterns associate with different specific individual CIDs. This highlights the heterogeneity of HF subtypes and changes over time across different CIDs.
KW - Autoimmune diseases
KW - Cardiomyopathy
KW - Heart failure
KW - Inflammation
KW - Psoriasis
UR - http://www.scopus.com/inward/record.url?scp=85113724077&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113724077&partnerID=8YFLogxK
U2 - 10.1161/circheartfailure.121.008478
DO - 10.1161/circheartfailure.121.008478
M3 - Article
C2 - 34372666
AN - SCOPUS:85113724077
SN - 1941-3297
VL - 14
SP - 896
EP - 905
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 8
ER -